Fangyu Peng Selected Research

Fangyu Peng Research Topics

Disease

20	Neoplasms (Cancer) 04/2022 - 09/2005
11	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2005
7	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2011
7	Neuroblastoma 01/2019 - 08/2006
5	Hepatolenticular Degeneration (Wilson's Disease) 01/2017 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 09/2005
4	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2005
2	Melanoma (Melanoma, Malignant) 04/2022 - 01/2017
2	Wounds and Injuries (Trauma) 01/2017 - 08/2015
2	Necrosis 01/2012 - 02/2008
1	Papillary Thyroid Cancer 04/2024
1	Lymphadenopathy 03/2022
1	Lymphoma (Lymphomas) 03/2022
1	COVID-19 03/2022
1	Hodgkin Disease (Hodgkin's Disease) 03/2022
1	Pneumonia (Pneumonitis) 03/2022
1	Albuminuria 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Obesity 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Body Weight (Weight, Body) 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Inflammation (Inflammations) 01/2017
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Thyroiditis 01/2017
1	Thyroid Dysgenesis (Thyroid Agenesis) 01/2017
1	Rhinorrhea 09/2016
1	Carcinoma (Carcinomatosis) 08/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2013
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Circulating Neoplastic Cells 01/2013

Drug/Important Bio-Agent (IBA)

21	CopperIBA 04/2022 - 09/2005
7	ChloridesIBA 04/2022 - 09/2005
6	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 08/2006
5	Copper Transporter 1IBA 04/2022 - 09/2005
5	Radioisotopes (Radionuclides)IBA 04/2022 - 01/2007
4	Copper-64IBA 04/2022 - 10/2012
4	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 07/2006
4	LigandsIBA 01/2019 - 09/2005
4	RadiopharmaceuticalsIBA 01/2019 - 09/2005
4	cupric chloride (copper(II) chloride)FDA Link 01/2017 - 04/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2022 - 08/2015
3	IonsIBA 01/2017 - 02/2008
2	ThiosemicarbazonesIBA 11/2017 - 01/2008
2	Trace Elements (Biometals)IBA 01/2017 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2015
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2013 - 09/2005
2	Tryptophan (L-Tryptophan)FDA Link 03/2009 - 05/2007
2	pyrrolidine dithiocarbamic acidIBA 02/2008 - 09/2005
2	prolinedithiocarbamate (PDTC)IBA 02/2008 - 09/2005
1	dabrafenibIBA 04/2024
1	trametinibIBA 04/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024
1	Copper-67IBA 04/2022
1	SteroidsIBA 12/2021
1	Sincalide FDA Link 12/2021
1	Insulin (Novolin)FDA Link 01/2021
1	NAD (NADH)IBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2020
1	Docetaxel (Taxotere)FDA Link 02/2020
1	FluoridesIBA 02/2020
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2019
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2019
1	cupric sulfide (CuS)IBA 07/2018
1	BombesinIBA 07/2018
1	Sulfides (Thioethers)IBA 07/2018
1	AcidsIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	LuciferasesIBA 01/2018
1	Saline SolutionIBA 01/2018
1	Green Fluorescent ProteinsIBA 11/2017
1	LipopolysaccharidesIBA 01/2017
1	IpilimumabIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	CY5.5 cyanine dyeIBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	cyclobutanecarbonylcarnitine (CBCC)IBA 01/2015
1	Radioactive TracersIBA 05/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 01/2013
1	MetalsIBA 01/2012
1	Copper Transport ProteinsIBA 01/2012
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 02/2008

Therapy/Procedure

12	Therapeutics 04/2024 - 09/2005
4	Drug Therapy (Chemotherapy) 03/2022 - 02/2008
3	Thyroidectomy 04/2024 - 08/2015
3	Precision Medicine 04/2022 - 05/2013
3	Radiotherapy 02/2020 - 05/2007
3	Intravenous Injections 01/2017 - 05/2013
1	Prostatectomy (Retropubic Prostatectomy) 02/2020
1	Aftercare (After-Treatment) 02/2020
1	Immunotherapy 01/2017
1	Intramuscular Injections 01/2017
1	Craniotomy 09/2016
1	Lymph Node Excision (Lymph Node Dissection) 08/2015
1	Chemoradiotherapy 05/2013